Full Schedule

8:00 AM – 8:15 AM

Welcome

Favorite

8:15 AM – 8:32 PM

Session 15: Debate - Will ASCT Continue to Be the Standard of Care in Frontline Therapy? - Yes

Presenter: Amrita Y. Krishnan, MD, FACP – City of Hope Comprehensive Cancer Center

Favorite

8:32 AM – 8:50 AM

Session 15: Debate - Will ASCT Continue to Be the Standard of Care in Frontline Therapy? - No

Presenter: C. Ola Landgren, MD, PhD – Sylvester Comprehensive Cancer Center, University of Miami

Favorite

8:49 AM – 9:00 AM

Session 15: Debate - Will ASCT Continue to Be the Standard of Care in Frontline Therapy? - Discussion

Moderator: Joseph Mikhael, MD, MEd, FRCPC, FACP – Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Panelist: Amrita Y. Krishnan, MD, FACP – City of Hope Comprehensive Cancer Center

Panelist: C. Ola Landgren, MD, PhD – Sylvester Comprehensive Cancer Center, University of Miami

Favorite

9:00 AM – 9:15 AM

Break

Favorite

9:15 AM – 9:50 AM

Session 16: Optimal Frontline Therapy of Myeloma

Presenter: Peter M. Voorhees, MD – Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine

Favorite

9:50 AM – 10:00 AM

Live Q&A

Moderator: Joseph Mikhael, MD, MEd, FRCPC, FACP – Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Speaker: Peter M. Voorhees, MD – Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine

Favorite

10:00 AM – 10:15 AM

Break

Favorite

10:15 AM – 11:15 AM

Non-CME Innovation Theater - Sponsored by Janssen

Favorite

11:15 AM – 11:30 AM

Break

Favorite

11:30 AM – 12:05 PM

Session 17: Making Sense of the Choices in Relapsed Myeloma

Presenter: Joseph Mikhael, MD, MEd, FRCPC, FACP – Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Favorite

12:05 PM – 12:15 PM

Live Q&A

Speaker: Joseph Mikhael, MD, MEd, FRCPC, FACP – Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Panelist: Peter M. Voorhees, MD – Levine Cancer Institute, Atrium Health / Wake Forest School of Medicine

Favorite

12:15 PM – 12:30 PM

Break

Favorite

12:30 PM – 1:05 PM

Session 18: Relapsed/ Refractory Multiple Myeloma: Novel and Cellular Therapies in 2023

Presenter: Saad Z. Usmani, MD, MBA, FACP – Memorial Sloan Kettering Cancer Center

Favorite

1:05 PM – 1:15 PM

Live Q&A

Moderator: Joseph Mikhael, MD, MEd, FRCPC, FACP – Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Speaker: Saad Z. Usmani, MD, MBA, FACP – Memorial Sloan Kettering Cancer Center

Favorite

1:15 PM – 1:30 PM

Break

Favorite

1:30 PM – 2:15 PM

Session 19: The Future of Myeloma

Presenter: Thomas G. Martin, MD – UCSF Medical Center

Favorite

2:15 PM – 2:30 PM

Break

Favorite

2:30 PM – 3:05 PM

Session 20: Health Disparity in MM and How to Overcome It in the Clinic

Presenter: Craig Emmitt Cole, MD – Michigan State University College of Human Medicine-Karmanos Cancer Institute

Favorite

3:05 PM – 3:15 PM

Live Q&A

Moderator: Joseph Mikhael, MD, MEd, FRCPC, FACP – Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Speaker: Craig Emmitt Cole, MD – Michigan State University College of Human Medicine-Karmanos Cancer Institute

Favorite

3:15 PM – 3:30 PM

Break

Favorite

3:30 PM – 4:05 PM

Session 21: How Do I Diagnose and Treat AL Amyloidosis?

Presenter: Michael Rosenzweig, MD – City of Hope

Favorite

4:05 PM – 4:15 PM

Live Q&A

Moderator: Joseph Mikhael, MD, MEd, FRCPC, FACP – Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Speaker: Michael Rosenzweig, MD – City of Hope

Favorite